February 26, 2021
Daiichi Sankyo and LYSA-LYSARC-CALYM, a community of over 800 lymphoma researchers in France and Belgium, said on February 24 that they have formed a strategic research collaboration to study valemetostat (DS-3201) in B-cell malignancies. Under the deal, the partners will...read more